Ethambutol/isoniazid/rifampicin

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Ethambutol/isoniazid/rifampicin
Combination of
ethambutolanti-tuberculosis medication
isoniazidanti-tuberculosis medication
rifampicinanti-tuberculosis medication
Clinical data
ATC code
Identifiers
ChemSpider
  • none

Ethambutol/isoniazid/rifampicin, also known as ethambutol/isoniazid/rifampin, is a medication used to treat tuberculosis.[1] It is a fixed dose combination of ethambutol, isoniazid, and rifampicin.[1] It is used either along or with other antituberculosis medication.[1] It is taken by mouth.[1] Side effects are those of the underlying medications.[1] Use may not be suitable in children.[1]

It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.[2] The wholesale cost in the developing world is about 6.74 to 16.13 USD a month.[3]

See also[edit]

References[edit]

  1. ^ a b c d e f WHO Model Formulary 2008 (PDF). World Health Organization. 2009. p. 142. ISBN 9789241547659. Archived (PDF) from the original on 13 December 2016. Retrieved 8 December 2016.
  2. ^ "WHO Model List of Essential Medicines (19th List)" (PDF). World Health Organization. April 2015. Archived (PDF) from the original on 13 December 2016. Retrieved 8 December 2016.
  3. ^ "Rifampicin + Isoniazid + Ethambutol". International Drug Price Indicator Guide. Retrieved 8 December 2016.